Announcement
The latest AI breast cancer identification system, Transpara™ 1.6 will be showcased at RSNA 2019
1st December 2019
The latest AI breast cancer identification system, Transpara™ 1.6 will be showcased at RSNA 2019
The most advanced version of Transpara™ from ScreenPoint Medical unleashes the power from 2D into 3D mammography: Performance is better, faster and even more accurate.
Transpara™ 1.6, the leading Artificial Intelligence decision support system for breast cancer screening, that uses deep learning algorithms to automatically detect potential breast cancer in 2D and 3D DBT mammograms, will be unveiled at the Annual Radiological Society of North America (RSNA) meeting, December 1-6, 2019 (ScreenPoint Medical, South Hall #4380).